To prevent the development of malignancies, mammalian cells activate disposal programs, such as programmed cell death, in response to deregulated oncogene expression. However, the molecular basis for regulation of cellular disposal machinery in response to activated oncogenes is unclear at present. In this study, we show that upregulation of the autophagy-related protein, Atg5, is critically required for the oncogenic H-ras-induced autophagic cell death and that Rac1/mitogen-activated kinase kinase (MKK) 7/c-Jun N-terminal kinase (JNK) signals upregulation of Atg5. Overexpression of H-ras V12 induced marked autophagic vacuole formation and cell death in normal fibroblasts, which remained unaffected by a caspase inhibitor. Pretreatment with Bafilomycin A1, an autophagy inhibitor, completely attenuated H-ras V12 -induced cell death as well as autophagic vacuole formation. Selective production of Atg5 was observed in cells overexpressing H-ras V12 , and small interfering RNA (siRNA) targeting of Atg5 clearly inhibited autophagic cell death. Interestingly, inhibition of JNK or c-Jun by specific siRNA suppressed Atg5 upregulation and autophagic cell death. Moreover, inhibition of MKK7, but not MKK4, effectively attenuated H-ras V12 -induced JNK activation. In addition, ectopic expression of RacN17 or Rac1-siRNA effectively inhibited MKK7-JNK activation, Atg5 upregulation and autophagic cell death. These data support the notion that upregulation of Atg5 is required for the oncogenic H-ras-induced autophagic cell death in normal fibroblasts and that activation of Rac1/MKK7/JNK-signaling pathway leads to upregulation of Atg5 in response to oncogenic H-ras. Our findings suggest that in cells acquiring deregulated oncogene expression, oncogenic stress triggers autophagic cell death, which protects cells against malignant progression.
Introduction
Oncoproteins of the Ras family have been extensively analyzed because of their involvement in human cancer. Uncontrolled Ras activation is one of the most common genetic alterations associated with human cancer. Point mutations in the ras gene occur at high frequency in mammalian cells, resulting in malignant transformation and further progression to cancer (1) . In fact, oncogenic Ras mutations are found in .30% of all human malignancies (2) . Ras guanosine triphosphatases act as molecular switches to transduce extracellular signals to the nucleus, where they regulate an overlapping set of cellular responses. These proteins participate primarily in cell proliferation and suppression of apoptosis, as evident from Ras activation in the signal transduction pathways triggered by various stimuli (3) . However, Ras functions have been extended in recent years to include the initiation of programmed cell death in signal transduction pathways (4) (5) (6) (7) . This pro-apoptotic activity has been confirmed in a number of experimental systems, both for Ras and Ras effectors (8) (9) (10) . Despite multiple reports demonstrating a requirement for Ras in cell death processes, relatively limited information is available on the molecular and biochemical mechanisms of Ras action in the regulation of programmed cell death.
Programmed cell death, an important means to exclude abnormalities and prevent emerging malignancies, is a prominent mechanism for tumor suppression (11) . This process is subdivided into at least two major subtypes, specifically, apoptotic and autophagic cell death. Apoptosis is a well-defined cell death pathway that is conserved from nematodes to humans. The caspase family of cysteine proteases plays a central role in apoptotic signaling and cell execution. Autophagic cell death is a non-apoptotic form of programmed cell death, an evolutionally conserved genetically controlled process that regulates the normal turnover of proteins and organelles and removes those with compromised function to maintain homeostasis (12) . Apoptosis and autophagic cell death are alternative pathways that lead to the same end and act as backup mechanisms for each other under conditions where cell death is inevitable (13) .
Autophagy is a dynamic process that prolongs survival for a short time under starvation conditions. A membrane forms around the targeted cytoplasm, and organelles fuse with a lysosome or vacuole, resulting in subsequent degradation of organelle contents and recycling to maintain cell viability (14, 15) . Certain forms of cell death are prevented either with autophagic inhibitors or by reduced Atg gene expression, implying that autophagy triggers and participates directly in the cell death mechanism (13, 16, 17) . Autophagy-related cell death is characterized by the accumulation of autophagic vesicles, autophagosomes and autophagolysosomes, often occurring when extensive cell elimination is required (18, 19) . Consistently, large-scale induction of autophagy destroys severely damaged cells as a defense mechanism against cancers (20) (21) (22) . Based on these findings, it is proposed that defects in this pathway confer a selective survival advantage to cells, resulting in cancer.
To prevent the development of malignancies, mammalian cells activate cellular disposal programs, such as programmed cell death, in response to deregulated oncogene expression. However, the molecular basis for regulation of cellular disposal machinery in response to activated oncogenes is unclear at present. In this study, we investigated the molecular mechanism of oncogenic Ras-induced autophagic cell death in normal fibroblasts. Our data show that upregulation of Atg5 is essentially involved in autophagic vacuole formation and caspase-independent cell death in response to oncogenic Ras and that activation of the Rac1/mitogen-activated kinase kinase (MKK) 7/c-Jun N-terminal kinase (JNK)/c-Jun-signaling pathway promotes upregulation of Atg5.
Chemical reagents and antibodies
Pan-caspase inhibitor, actinomycin D, propidium iodide (PI), dimethyl sulfoxide and N-acetyl-cystein were purchased from Sigma (St Louis, MO). Caspase 3 inhibitor, cyclohexamide, Bafilomycin A1, PD98059, SB203580 and SP600125 were purchased from Calbiochem (San Diego, CA). LysoTracker-Green DND-26 was purchased from Molecular Probe (L-7526; Invitrogen, Carlsbad, CA). Polyclonal antibodies to anti-phospho-extracellular signalregulated kinase (ERK), p38 mitogen-activated protein kinase (MAPK), caspase 8, caspase 9, caspase 3, c-jun and Atg6 (beclin 1) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Polyclonal anti-Atg5, LC3 and lysosomal associated membrane protein-1 (LAMP-1) were obtained from Abgent (San Diego, CA). Polyclonal antibodies to poly adenosine diphosphate-ribose polymerase, ERK, JNK, phospho-JNK, phospho-p38 MAPK, MKK4, phospho-MKK4, MKK7, phospho-MKK7 and phospho-cjun were obtained from Cell Signaling Technology (Beverly, MA). Monoclonal anti-b-actin was obtained from Sigma.
Quantification of cell death
Flow cytometric analysis using PI (2.5 lg/ml) staining detects cell death by means of the dye entering the cells along with changes in the target cell membrane and DNA damage. For the cell death assessment, the cells were plated in 60 mm dish with cell density of 1 Â 10 5 cells per dish and infected with H-ras V12 . At indicated time points, cells were harvested by trypsinization, washed in phosphate-buffered saline and then incubated in PI for 5 min at room temperature. Then, cells (10 000 per sample) were analyzed on a flow cytometric scan flow cytometer, using Cell Quest software.
Transmission electron microscopy Cells incubated as described above were pelleted and fixed with 3% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4, for 120 min, washed three times and postfixed in osmium tetroxide 1% for 60 min. The cells were dehydrated in an ascending ethanol battery ranging from 20 to 100% and were later placed in 3:1, 2:1, 1:1, 1:2 and 1:3 ratios of propylene oxide or epon-812 resin for 1 h at room temperature, respectively. Ultrathin sections of 70 nm were made and impregnated with 2% uranyl acetate and Reynold's lead citrate. The sections were visualized in a Zeiss EM-900 transmission electron microscope at 50 kV and photographed. The negatives were scanned at 600 Â 600 dpi resolution, and the images obtained were analyzed later with a PC-compatible computer using customized software.
Small interfering RNA transfection
Small interfering RNA (siRNA) targeting of Atg5, p38 MAPK, ERK1, JNK1 and c-jun were performed using 21 bp (including a 2-deoxynucleotide overhang) and purchased from Ambion (Austin, TX). A control siRNA specific for green fluorescent protein (CCACTACCTGAGCACCCAG) was used as the negative control. Cells were plated on 100 mm dishes at 30% confluency, and siRNA duplexes (50 nM) were introduced into cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) by following the procedure recommended by the manufacturer.
Western blot analysis
Cell lysates were prepared by extracting proteins with lysis buffer [40 mM Tris-HCl (pH 8.0), 120 mM NaCl, 0.1% Nonidet-P40] supplemented with protease inhibitors. Proteins were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (Amersham Biosciences, Arlington Heights, IL). The membrane was blocked with 5% nonfat dry milk in Tris-buffered saline and incubated with primary antibodies for overnight at 4°C. Blots were developed with a peroxidase-conjugated secondary antibody and proteins visualized by enhanced chemiluminescence procedures (Amersham), using the manufacturer's protocol.
RNA isolation and reverse transcription-polymerase chain reaction RNA was isolated using the RNeasy kit (QIAGEN, Valencia, CA). RNA was treated with DNase I (Ambion) to eliminate any contaminating DNA. Reverse transcription-polymerase chain reaction reactions were performed with Super-Script III (Invitrogen) according to the manufacturer's instructions. Primer sequences and amplification conditions are described as follows: atg5 (forward, 5-CTCRGCCTTGGAACATCACA-3), (reverse, 5-AGGGTATGCAGCTGTC-CATC-3); atg6 (forward, 5-ACCGAAAGGUGGUGGCAGA-3), (reverse, 5-UGUGCCACCACCUUUCGGU-3); atg7 (forward, 5-CAAAGCCTCCAAA-ATTCAGC-3), (reverse, 5-GAAGCAGAAAGGCAGCATA-3) and gapdh (forward, 5-CCATGGAGAAGGCTGGGG-3), (reverse, 5-CAAAGTTGT-CATGGATGACC-3).
Phase-contrast and fluorescence microscopy
Cells were seeded 60 mm dish and 24 h later, cells were transfected with MFG-H-ras V12 or MFG control and dimethyl sulfoxide or inhibitors are added. And 48 h after, cells were imaged by phase-contrast microscopy. (Leica Microsystems, Bannockburn, IL). To visualize acidic vacuole in H-ras V12 -overexpressed cells or control cells at 48 h after infection, cells were stained with 50 nM LysoTracker-Green DND-26 (L-7526, Molecular Probe) fluorescence dye for 10 min and washed with phosphate-buffered saline and then changed to culture media. Cells were imaged by fluorescence microscopy (Leica Microsystems).
Statistical analysis
All experimental data are reported as mean and the error bars represent the experimental standard error. Statistical analysis was performed by the non-parametric Student's t-test.
Results

Oncogenic Ras induces caspase-independent cell death in normal fibroblasts
To determine whether oncogenic Ras might induce cell death in normal fibroblasts, we infected cells with oncogenic H-ras (H-ras V12 ) using a retroviral expression vector and analyzed cell death by flow cytometric analysis. Infection of three different normal fibroblasts, Rat2, NIH3T3 and WI38 with H-ras V12 caused notable levels of cell death after 72 h ( Figure 1A ). Approximately 40% of Rat2 cells underwent cell death by 72 h in response to H-ras V12 expression. Moreover, the caspase inhibitors were unable to attenuate oncogenic H-ras-induced cell death ( Figure 1A ). Furthermore, western blot analysis failed to reveal cleavage of pro-caspases to their active counterparts or appearance of the caspase substrate, poly adenosine diphosphate-ribose polymerase, at any time after transfection ( Figure 1B ). Thus, it appears that oncogenic H-ras-induced cell death in normal fibroblasts occurs in a caspase-independent manner. On the other hand, overexpression of oncogenic H-ras was associated with massive vacuole formation in all three different normal fibroblasts ( Figure 1C) . A time-course light microscopy study revealed that vacuolated cells accumulated at 24 and 48 h before cell death in response to oncogenic H-ras. At 48 h after infection, .50% of cells contained at least one vacuole filling most of the cellular compartment, followed by a marked reduction in vacuolated cells at 72 h, consistent with caspase-independent cell death.
Autophagic vacuole formation is related to oncogenic H-ras-induced caspase-independent cell death
To determine whether vacuolation in oncogenic H-ras-infected cells was associated with autophagy, we first performed LysoTracker-Green staining. As shown in Figure 2A , oncogenic H-ras induced extensive LysoTracker positive acidic vacuole formation in normal fibroblasts 48 h after infection (Figure 2A ). Moreover, transfection of cells with green fluorescent protein (GFP)-tagged LC3 showed that punctuate GFP-LC3 positive cells were increased by oncogenic H-ras ( Figure 2B ). Oncogenic H-ras also induced increase in LC3-II, a processed form of LC3 ( Figure 2C ), indicating oncogenic H-ras-induced the accumulation of autophagic vesicles. To further detect LAMP-1, we examined colocalization of autophagosome marker LC3 and LAMP-1. As shown in Figure 2D , infection of cells with oncogenic H-ras induced colocalization of LC3 and LAMP-1, indicating lysosomal localization of LC3 protein. Transmission electron microscopy also revealed oncogenic H-ras-induced increase in single membrane vesicles with electrodense materials (Figure 2E ). To further establish whether oncogenic H-ras-induced vacuolation was attributable to the autophagic pathway and to examine whether autophagy induction might be correlated with caspase-independent cell death, we pretreated cells with Bafilomycin A1, a specific inhibitor of adenosine triphosphate synthesis of forming autophagy process, and 3methyladenine, an inhibitor of the class III phosphatidylinositol 3-kinases known to be involved in sequestration, i.e. the first step of autophagy. Pretreatment of Bafilomycin A1 or 3-methyladenine Signaling pathway for oncogenic Ras-induced autophagic cell death completely blocked oncogenic H-ras-induced autophagy ( Figure 2F and supplementary Figure S1A is available at Carcinogenesis Online) and cell death ( Figure 2G and supplementary Figure S1B is available at Carcinogenesis Online) in three different fibroblasts. These results indicate that overexpression of oncogenic H-ras induces substantial autophagy, which is related to caspase-independent cell death.
Atg5 is involved in autophagy and caspase-independent cell death triggered by oncogenic Ras Expression patterns of autophagy-related (Atg) genes under specific conditions provide key information about the autophagic process (13, 16, 17) . The transcriptional inhibitor, actinomycin D, and protein synthesis inhibitor, cycloheximide, significantly attenuated oncogenic H-ras-induced autophagy and subsequent cell death ( Figure  3A) , indicating a requirement for de novo protein synthesis. Consequently, we examined alterations in the expression patterns of key Atg proteins in response to oncogenic H-ras and analyzed whether changes in Atg expression contributed to autophagy and subsequent cell death. As shown in Figure 3B , cells expressing oncogenic H-ras displayed a selective increase in Atg5 messenger RNA and protein levels. Moreover, siRNA targeting of Atg5 effectively attenuated oncogenic H-ras-induced autophagy ( Figure 3C and supplementary Figure S2A is available at Carcinogenesis Online) as well as cell death ( Figure 3D and supplementary Figure S2B is available at Carcinogenesis Online) in normal fibroblasts. The data strongly suggest that upregulation of Atg5 expression is required for auto-phagic vacuole formation and non-apoptotic cell death induced by oncogenic H-ras.
JNK activation is critical for Atg5 upregulation, autophagy and subsequent cell death in response to oncogenic H-ras MAPK is an essential downstream effector of Ras and mediates Rasinduced diverse cellular events (23) . To investigate the potential involvement of MAPK in oncogenic H-ras-induced autophagy and cell death (24) , we initially analyzed the activation status of ERK, JNK and p38 MAPK by immunoblotting with antibodies specific for the phosphorylated forms of these kinases. As expected, infection of cells with oncogenic H-ras resulted in a dramatic increase in the phosphorylated forms of all three MAPKs, implying activation in response to H-ras ( Figure 4A ). To further ascertain whether active MAPK was required for autophagy and subsequent cell death, cells were pretreated with a specific chemical inhibitor or siRNA, prior to infection with oncogenic H-ras. Inhibition of JNK with SP600125 or specific siRNA prevented autophagy ( Figure 4B ) and cell death ( Figure 4C) induction by oncogenic H-ras. Inhibition of JNK also clearly attenuated oncogenic H-ras-induced upregulation of Atg5 messenger RNA and protein expression ( Figure 4D ). However, pretreatment with a chemical inhibitor or siRNA-targeting ERK or p38 MAPK did not affect autophagy, cell death and Atg5 expression. Based on these findings, we propose that JNK activation acts as a signal for upregulation of Atg5, autophagy and subsequent non-apoptotic cell death in response to oncogenic H-ras expression. We additionally showed that Signaling pathway for oncogenic Ras-induced autophagic cell death is available at Carcinogenesis Online) and cell death (supplementary Figure S3D is available at Carcinogenesis Online).
MKK7 is an upstream regulator of JNK-mediated Atg5 and autophagic cell death
The JNK-activating kinases, MKK4 and MKK7, are differentially required for JNK activity in response to extracellular stimuli (25) (26) (27) (28) . To explore any requirement for MKK4 or MKK7 in JNK-mediated autophagic cell death in response to oncogenic H-ras, we used dominant-negative forms of the proteins. Interestingly, phosphorylated MKK7, but not phosphorylated MKK4, was increased in cells expressing oncogenic H-ras, signifying activation of MKK7 ( Figure 5A ). Ectopic expression of dominant-negative MKK7 effectively prevented JNK and c-Jun activation ( Figure 5B ) and upregulation of Atg5 ( Figure 5C ). Moreover, inhibition of MKK7 attenuated autophagy ( Figure 5D ) and cell death ( Figure  5E ), whereas inhibition of MKK4 via use of a dominant-negative form of MKK4 had no significant effects. These results suggest that MKK7 selectively acts as an upstream regulator of the JNKmediated Atg5 induction pathway in oncogenic H-ras-stimulated autophagic cell death.
Rac1 is involved in oncogenic H-ras-induced Atg5 expression and subsequent autophagic cell death
Rac1 has been implicated in many cellular processes in response to various types of cellular stress (29) . We examined whether Rac1 might be involved in oncogenic H-ras-induced Atg5 expression and subsequent autophagic cell death. In cells overexpressing oncogenic H-ras, levels of Rac1-Pak binding were markedly increased ( Figure 6A ), indicating activation of Rac1. Moreover, inhibition of Rac1 with ectopic expression of RacN17 (MFG-HA-RacN17), a dominant-negative Rac1, or with siRNA targeting of Rac1 clearly attenuated oncogenic H-ras-induced Atg5 expression ( Figure 6A ), autophagy ( Figure 6B ) and cell death ( Figure 6C ). In addition, inhibition of Rac1 suppressed oncogenic H-ras-induced activation of MKK7 and JNK ( Figure 6A ). These results support the notion that Rac1 is essentially involved in activation of MKK7-JNK-signaling pathway that induces Atg5 expression and subsequent autophagic cell death in response to oncogenic H-ras.
Discussion
Cells avert the development of malignancy in response to deregulated oncogene expression by activating a regulated cell death pathway. Signaling pathway for oncogenic Ras-induced autophagic cell death However, the molecular mechanism underlying this oncogeneinduced cellular disposal process remains unclear. Here, we show that oncogenic H-ras induces autophagy and subsequent caspase-independent cell death through upregulation of Atg5, a key autophagy protein, in normal fibroblasts and that activation of Rac1/MKK7-JNK-c-Junsignaling pathway is necessary for Atg5 induction. Although oncoproteins of the Ras family are perhaps best known for their role in initiating cell proliferation and suppressing apoptosis, oncogenic Ras can, under certain conditions, initiate cell death (4, 6, 30, 31) . In this study, we provided further evidence that overexpression of oncogenic H-ras triggers cell death in normal cells through a caspase-independent mechanism. We also found that oncogenic H-ras leads to massive autophagic vacuole formation. Recent studies show that certain forms of cell death are prevented either with autophagic inhibitors or by reduced Atg gene expression, implying that autophagy initiates and participates directly in the death process (13, 16, 17) . Consistent with these findings, our results show that chemical inhibitors of autophagy completely blocked oncogenic Hras-induced cell death, suggesting that oncogenic H-ras induces autophagic cell death in normal fibroblasts. Recently, it has been also shown that autophagy is involved in cellular senescence, another tumor suppressor mechanism, induced by oncogenic Ras (30) . However, in the current study, we found no evidence for the induction of senescence in response to oncogenic H-ras in Rat2 normal fibroblasts (data not shown). We further observed selective Atg5 expression in cells overexpressing oncogenic H-ras. siRNA targeting of Atg5 clearly attenuated autophagy and cell death in response to oncogenic H-ras, signifying that upregulation of Atg5 is a critical event for oncogenic Ras-induced autophagy and cell death. This finding is in agreement with recent studies that Atg5 plays a role in cell death as well as autophagic vacuole formation induced by a variety of stimuli (31) (32) (33) (34) .
We provide further evidence that the JNK/c-Jun-signaling pathway participates in autophagy and subsequent caspase-independent cell death through upregulation of Atg5 in response to oncogenic H-ras. We found that inhibition of JNK or c-Jun attenuated upregulation of Atg5, autophagic vacuole formation and cell death, suggesting that JNK/c-Jun signaling is critically associated with the cell death mechanism stimulated by oncogenic H-ras. These results are in agreement with those of recent studies showing that JNK is actively involved in autophagy induced by a variety of stimuli, including endoplasmic reticulum stress (35) , caspase inhibition (36), insulin-like growth factor-1 treatment and exposure to tumor necrosis factor-alpha (37) .
Evidence for extensive cooperation and cross talk between guanosine triphosphatases and other signaling pathways is well documented. Rac1 is one of the well-characterized small guanosine triphosphatases and has been implicated in many cellular processes in response to various types of cellular stress (29) . In this study, we also found that Rac1 is involved in MKK7-JNK-mediated Atg5 expression and autophagic cell death in cells overexpressing oncogenic H-ras. When we inhibited Rac1 with ectopic expression of a dominant-negative Rac1, oncogenic H-ras-induced Atg5 expression and autophagic cell death were significantly attenuated. In addition, inhibition of Rac1 clearly suppressed activation of MKK7 and JNK.
These results suggest that Rac1 is essentially involved in activation of MKK7-JNK-signaling pathway that induces Atg5 upregulation and autophagic cell death in response to oncogenic H-ras.
Our results collectively demonstrate that upregulation of Atg5 expression is necessary for autophagic vacuole formation and caspase-independent cell death in response to oncogenic Ras in normal fibroblasts and that activation of Rac1/MKK7/JNK/c-Jun-signaling pathway is critically required for Atg5 upregulation. Our findings suggest that in cells acquiring deregulated oncogene expression, oncogenic stress triggers autophagic cell death, which protects against malignant progression.
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